Is HYHDF or MRK a better dividend investment in 2026?

HYHDF currently yields 6097.56% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: HYHDF offers higher current income.

What is the dividend yield difference between HYHDF and MRK?

HYHDF has a forward dividend yield of 6097.56% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 6094.80 percentage points.

Home › Compare › HYHDF vs MRK

HYHDF vs MRK: Dividend Comparison 2026

HYHDF yields 6097.56% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HYHDF wins by $429818330202647.94M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HYHDF

● Live price

6097.56%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$429818330202648.00M

Annual income

$416,385,209,432,446,500,000.00

Full HYHDF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — HYHDF vs MRK

📍 HYHDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HYHDF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HYHDF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HYHDF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYHDF

Annual income on $10K today (after 15% tax)

$518,292.68/yr

After 10yr DRIP, annual income (after tax)

$353,927,428,017,579,500,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, HYHDF beats the other by $353,927,428,017,579,500,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYHDF + MRK for your $10,000?

HYHDF: 50%MRK: 50%

100% MRK50/50100% HYHDF

Portfolio after 10yr

$214909165101324.03M

Annual income

$208,192,604,716,223,230,000.00/yr

Blended yield

96.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HYHDF

No analyst data

Altman Z

1.8

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYHDF buys

MRK buys

No recent congressional trades found for HYHDF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHYHDFMRK

Forward yield	6097.56% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$429818330202648.00M ✓	$56.8K
Annual income after 10y	$416,385,209,432,446,500,000.00 ✓	$9,798.13
Total dividends collected	$428914858769868.19M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HYHDF vs MRK ($10,000, DRIP)

Year	HYHDF Portfolio	HYHDF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$620,456	$609,756.10	$11,206	$366.19	+$609.3K → HYHDF
2	$36,021,541	$35,357,653.15	$12,650	$502.35	+$36.01M → HYHDF
3	$1,956,994,825	$1,918,451,775.49	$14,407	$694.19	+$1956.98M → HYHDF
4	$99,501,955,216	$97,407,970,754.10	$16,585	$967.82	+$99501.94M → HYHDF
5	$4,735,099,117,931	$4,628,632,025,849.62	$19,342	$1,363.89	+$4735099.10M → HYHDF
6	$210,923,887,127,540	$205,857,331,071,354.10	$22,913	$1,947.19	+$210923887.10M → HYHDF
7	$8,795,657,583,896,487	$8,569,969,024,670,019.00	$27,662	$2,823.89	+$8795657583.87M → HYHDF
8	$343,404,859,107,255,940	$333,993,505,492,486,700.00	$34,159	$4,173.35	+$343404859107.22M → HYHDF
9	$12,554,318,476,823,861,000	$12,186,875,277,579,096,000.00	$43,337	$6,308.80	+$12554318476823.82M → HYHDF
10	$429,818,330,202,648,000,000	$416,385,209,432,446,500,000.00	$56,776	$9,798.13	+$429818330202647.94M → HYHDF

HYHDF vs MRK: Complete Analysis 2026

HYHDF — Stock

Sixty Six Capital Inc. provides co-location and cloud computing services. The company engages in the high-performance computing, storage, and information processing activities. It also invests in various technology sectors, such as crypto tokens and crypto finance. The company was formerly known as Hydro66 Holdings Corp. and changed its name to Sixty Six Capital Inc. in April 2021. Sixty Six Capital Inc. is headquartered in London, the United Kingdom.

Full HYHDF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this HYHDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYHDF vs SCHD HYHDF vs JEPI HYHDF vs O HYHDF vs KO HYHDF vs MAIN HYHDF vs JNJ HYHDF vs ABBV HYHDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.